Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf207 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Tiffany L Breger und 22 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: HIV Infections, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Eunice Kennedy Shriver National Institute of Child Health & Human Development, DC CTSA, National Institutes of Health, Office of AIDS Research.
Abstract (Originalsprache)
Background
To reduce atherosclerotic cardiovascular disease (ASCVD) among US people with human immunodeficiency virus (HIV, PWH), it is critical to assess shortfalls in statin initiation. We aimed to describe patterns in clinically indicated statin initiation among demographically similar people with or at increased vulnerability to HIV.
Methods
Using data from the Multicenter AIDS Cohort Study and Women's Interagency HIV Study, we followed 842 men and 852 women with an indication for statin use based on 2013 American College of Cardiology/American Heart Association guidelines for statin initiation between January 2014 and March 2020. We estimated 2-year incidence of statin initiation stratified by demographic, clinical, and behavioral characteristics and compared estimates using incidence differences.
Results
Within 2 years of statin indication, 20% of participants reported statin use. Initiation of statin therapy did not differ significantly by HIV status. However, initiation was lower among Black versus non-Black persons, especially among men (14.0% versus 22.3%; difference, −8.3%; 95% confidence interval, −13.8% to −2.8%). Compared with initiation among persons indicated based only on ≥7.5% 10-year predicted ASCVD risk (incidence: men, 14.2%; women, 15.2%), initiation was higher among those with existing ASCVD (incidence: men, 32.9%; women, 22.0%) or diabetes (incidence: men, 26.4%; women, 24.5%). Initiation was lower among current versus noncurrent smokers and higher among those with comorbidities.
Conclusions
Guideline-driven statin initiation was low, with large inequities by race. With indications for statin use expanding for PWH, redressing barriers to guideline implementation will be crucial to achieving improved outcomes through uptake of these evidence-based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- UNC Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- School of Medicine, Emory University, Atlanta, Georgia, USA.
- Department of Medicine/Infectious Diseases, Georgetown University, Washington, DC, USA.
- Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
ORCID-Profile: Tiffany L Breger, Daniel J Westreich, Andrew Edmonds, Jessie K Edwards, Catalina Ramirez, Igho Ofotokun, Deborah Konkle-Parker, Tonya N Taylor, M Bradley Drummond, Michelle A Floris-Moore
Förderung
- Eunice Kennedy Shriver National Institute of Child Health & Human Development
- DC CTSA
- National Institutes of Health, Office of AIDS Research
- NINR NIH HHS
- NIAID NIH HHS
- Atlanta CFAR
- NIAAA NIH HHS
- UAB CFAR
Zitieren
APA
Breger, T. L., Westreich, D. J., Edmonds, A., Edwards, J. K., Cole, S. R., Ramirez, C., Diggs, A. E., Ofotokun, I., Kassaye, S. G., Brown, T. T., Konkle-Parker, D., Palella, F. J., Krier, S., Jones, D. L., D'Souza, G., Cohen, M. H., Tien, P. C., Taylor, T. N., Anastos, K., …, & Floris-Moore, M. A. (2025). Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf207
Vancouver
Breger TL, Westreich DJ, Edmonds A, Edwards JK, Cole SR, Ramirez C, et al. Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf207
BibTeX
@article{Breger2025,
author = {Breger, Tiffany L and Westreich, Daniel J and Edmonds, Andrew and Edwards, Jessie K and Cole, Stephen R and Ramirez, Catalina and Diggs, Alicia E and Ofotokun, Igho and Kassaye, Seble G and Brown, Todd T and Konkle-Parker, Deborah and Palella, Frank J and Krier, Sarah and Jones, Deborah L and D'Souza, Gypsyamber and Cohen, Mardge H and Tien, Phyllis C and Taylor, Tonya N and Anastos, Kathryn and Hinderliter, Alan L and Eron, Joseph J and Drummond, M Bradley and Floris-Moore, Michelle A},
title = {Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf207}
}
EUVIMED